Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 100, Issue 8, Pages 635-638Publisher
WILEY
DOI: 10.1002/jso.21196
Keywords
neuroendocrine tumor; hepatic metastases; cytoreductive surgery; radiofrequency ablation
Ask authors/readers for more resources
The indolent nature of neuroendocrine tumors and their proclivity to be hormonally active warrant aggressive treatment for advanced stage disease with hepatic metastases. Cytoreduction has been associated with improved symptom control as well as prolonged survival compared with those treated with medical therapy. The primary modalities of cytoreduction employed are resection, ablation, and embolization. In particular, radiofrequency ablation has been utilized with good results and minimal morbidity for treating patients with advanced neuroendocrine disease. J. Surg. Oncol. 2009;100:635-638. (C) 2009 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available